ror,sponsor_name,sponsor_article,number_of_trials,number_of_trials_10_years,indicator_10_years,number_of_trials_10_years_drug,indicator_10_years_drug,number_of_trials_10_years_within_12_months,indicator_10_years_within_12_months,number_of_trials_10_years_within_12_months_drug,indicator_10_years_within_12_months_drug,number_of_trials_10_years_france,indicator_10_years_france,number_of_trials_10_years_drug_france,indicator_10_years_drug_france,number_of_trials_10_years_within_12_months_france,indicator_10_years_within_12_months_france,number_of_trials_10_years_within_12_months_drug_france,indicator_10_years_within_12_months_drug_france
00pg5jh14,Assistance Publique – Hôpitaux de Paris,de l',1023,664,38 %,187,44 %,664,19 %,187,21 %,9703,51 %,3667,76 %,9703,32 %,3667,53 %
